Scilex (SCLX US)

Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido® for postherpetic neuralgia, ELYXYB® for migraine, and GLOPERBA® for gout flares. The company is headquartered in Palo Alto, California, and was founded in 2019.